Author's Posts

Burrell Jacqueline

SCDAA Shines the Light on Sickle Cell

  • June 15, 2020
  • Burrell Jacqueline

SCDAA SHINES THE LIGHT ON SICKLE CELL Join SCDAA’s Twitter Party June 19, 2020 9 a.m. – 9 p.m. (June 15,... Continue Reading

ASH and FDA Unveil New Recommendations to Guide Clinical Development of Sickle Cell Disease Therapies

  • December 13, 2019
  • Burrell Jacqueline

Joint FDA/ASH Led Initiative Highlights Importance of Using Patient Reported Outcomes and Biomarkers in Clinical Trials to Advance SCD Therapies (WASHINGTON,... Continue Reading

GBT’s Oxbryta™ (voxelotor) tablets is approved for the treatment of sickle cell disease

  • December 3, 2019
  • Burrell Jacqueline

Oxbryta™ (voxelotor) tablets Now Approved On behalf of GBT, we are happy to share that Oxbryta (pronounced ox-brye-ta) is now approved... Continue Reading

New Hope for a Sickle Cell Cure

  • December 2, 2019
  • Burrell Jacqueline

How gene therapy is helping children with this devastating disease. By Joy Harrington, Writer When Mr. and Mrs. Jones married and left... Continue Reading

FDA Approves Global Blood Therapeutics Sickle Cell Disease Drug

  • November 26, 2019
  • Burrell Jacqueline

(Reuters) – The U.S. Food and Drug Administration said on Monday it approved a drug from Global Blood Therapeutics Inc to... Continue Reading

CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data

  • November 19, 2019
  • Burrell Jacqueline

Nov 19, 2019 CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data From First Two Patients Treated With Investigational CRISPR/Cas9... Continue Reading

US approves new drug to manage sickle cell disease

  • November 18, 2019
  • Burrell Jacqueline

By LINDA A. JOHNSON | November 15, 2019 | U.S. regulators on Friday approved a new medicine that can help... Continue Reading

Novartis Adakveo approved by FDA for Sickle Cell Disease

  • November 16, 2019
  • Burrell Jacqueline

New Novartis medicine Adakveo® (crizanlizumab-tmca) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell disease Sickle... Continue Reading

New Children’s Book Aims to Inspire Children with SCD

  • September 19, 2019
  • Burrell Jacqueline

Two health educators have written a children’s book about living with sickle cell disease (SCD). I’m No Different Than You tells... Continue Reading

SCDAA President and CEO Receives Award from National Association of Real Estate Brokers (NAREB)

  • September 16, 2019
  • Burrell Jacqueline

Sickle Cell Disease Association of America, Inc. (SCDAA) is proud to announce that SCDAA President and CEO Beverley Francis-Gibson was honored... Continue Reading

Donate Blood to Support Sickle Cell Patients

  • September 10, 2019
  • Burrell Jacqueline

September is Sickle Cell Awareness Month; Red Cross blood and platelet donations needed for patients This school year students battling sickle... Continue Reading

GBT and SCDAA to Host 8th Annual Sickle Cell Disease (SCD) Therapeutics Conference

  • September 5, 2019
  • Burrell Jacqueline

GlobalBlood Therapeutics, Inc. (GBT) (NASDAQ: GBT) and the Sickle Cell Disease Association of America, Inc. (SCDAA) announced that they will host... Continue Reading

SCDAA Announces New Keynote Speaker for Convention

  • September 3, 2019
  • Burrell Jacqueline

SCDAA is excited to welcome Marie Olivieri Russell, MD as a keynote speaker  at the 47th Annual National Convention this October... Continue Reading

SCDAA Hires New Communications and Public Relations Manager

  • August 27, 2019
  • Burrell Jacqueline

SCDAA welcomes Jacqueline Burrell, Principal of J Burrell Communications, LLC, as Communications and Public Relations Manager. Burrell has a wealth of... Continue Reading

Convention Keynote Speaker Announced

  • August 13, 2019
  • Burrell Jacqueline

SCDAA is excited to feature Dr. Amanda Brandow as a keynote speaker at the 47th Annual National Convention in October. In... Continue Reading

Powered by DoJiggy Nonprofit Website Hosting